Printer Friendly
The Free Library
19,573,962 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

A New Generation of Noninvasive Tests Holds Promise for Early Cancer Detection; New Survey by Greystone Associates Examines Diagnostic Potential and Market Impact.


Business Editors/Health/Medical Writers

AMHERST, N.H.--(BUSINESS WIRE)--April 20, 2004

Cancer screening has long been viewed as a way to avoid the morbidity and mortality Morbidity and Mortality can refer to:
  • Morbidity & Mortality, a term used in medicine
  • Morbidity and Mortality Weekly Report, a medical publication
See also
  • Morbidity, a medical term
  • Mortality, a medical term
 associated with this family of diseases, while helping to control the rising costs associated with treatment. However, until recently techniques for detecting the presence of cancerous cells in the general population have been disappointing and marked by accuracy and sensitivity limitations and patient compliance issues. A new survey by Greystone Associates has identified a number of new and emerging methods that will significantly improve the ability of clinicians to detect certain types of cancers noninvasively and more reliably.

New methods based upon such cutting-edge techniques as protein pattern identification, optical fluorescence, and DNA analysis DNA analysis Any technique used to analyze genes and DNA. See Chromosome walking, DNA fingerprinting, Footprinting, In situ hybridization, Jeffries' probe, Jumping libraries, PCR, RFLP analysis, Southern blot hybridization.  are creating new tools for caregivers and hold the promise of early detection for several important forms of cancer. Some of these new tests are improvements over existing methods that suffer from inaccuracies and a lack of specificity. Others represent potential breakthroughs for cancers with historically high mortality rates such as ovarian cancer ovarian cancer

Malignant tumour of the ovaries. Risk factors include early age of first menstruation (before age 12), late onset of menopause (after age 52), absence of pregnancy, presence of specific genetic mutations, use of fertility drugs, and personal history of breast
, where the absence of an accurate screening method has prevented early detection in the vast majority of cases.

"Evolving approaches to cancer detection that rely on advances in immunochemistry Immunochemistry

A discipline concerned both with the structure of antibody (immunoglobulin) molecules and with their ability to bind an apparently limitless number of diverse chemical structures (antigens); with the structure, organization, and rearrangement
 and our growing understanding of cancer cell physiology Cell physiology (or cellular electrophysiology) is the biological study of the cell's mechanism and interaction in its environment.

In the context of human physiology, cell physiology is often the term used to describe the physiology of membrane transport, neuron
 have resulted in noninvasive tests that are effective in detecting several forms of cancer," explains George Perros, Greystone Associates Managing Director. "Increasingly these advances are the result of the convergence of cancer marker detection and computerized analysis."

The survey's findings are contained in a new report researched and written by Greystone Associates. Noninvasive Cancer Test Kits: Evolving Technologies, Emerging Opportunities analyzes new and emerging cancer tests and examines the technology, regulatory and business factors that will influence their impact on the healthcare industry. More information is available at www.greystoneassociates.org

About Greystone

Greystone Associates is a medical and healthcare technology consulting firm Noun 1. consulting firm - a firm of experts providing professional advice to an organization for a fee
consulting company

business firm, firm, house - the members of a business organization that owns or operates one or more establishments; "he worked for a
 providing services in strategic planning Strategic planning is an organization's process of defining its strategy, or direction, and making decisions on allocating its resources to pursue this strategy, including its capital and people. , venture development, product commercialization, and technology and market assessment.
COPYRIGHT 2004 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2004, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:1USA
Date:Apr 20, 2004
Words:329
Previous Article:AppIQ Storage Area Management Solutions Gain Market Momentum; 30 New Customers in 10 Different Countries Select AppIQ Technology, Sales Increase 300...
Next Article:The Tolly Group Chooses Azimuth's W-Series for 802.11 Wireless LAN Testing.



Related Articles
``The Early Show'' on CBS Previews Lifeline BioTechnologies' First Warning System.
RESEARCHERS MAKE STRIDES IN URINE TEST FOR BLADDER CANCER.
MATRITECH/SYSMEX TO DEVELOP AUTOMATED PAP SMEAR TEST.
Noninvasive Technologies Becoming a Key Element in Pharmaceutical Strategies.
Biomoda Inc. Readies Products to Assist Medicare and Private Insurer Reimbursement Outsourcing to Speed Entry into Commercial Cancer Detection and...
Epigenomics to Develop Remote Sample Tests to Identify People with Stage I Colorectal Cancer in 2008/2009.
Matritech Announces Addition of Vice President of Sales; David Kolasinski, 30 Year Accomplished Sales Veteran, Joins Management Team.
New Generation of Diagnostic Imaging Agents Raising Expectations and Expanding Applications; Greystone Associates Analyzes Trend toward Metabolic and...
Biomoda Inc. to Collaborate on Validation Study for Early Noninvasive Lung Cancer Diagnostic Testing.
Comprehensive Coverage of Clinical Applications of First- and Next-Generation Molecular Diagnostics.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles